scholarly publishing

The plan’s signatories seek to make the results of their funded research available to all, but some scientists say the transition to open access has led to climbing publication fees and could exacerbate global disparities.

A response to Ada Hagan’s opinion piece suggesting that our study “compromises response to gender bias.”

A recent analysis that claimed no evidence of gender-based peer review outcomes fails to account for several factors.

An analysis of data from nearly 150 journals across scientific disciplines finds that, if anything, manuscripts authored by women are treated more favorably than those submitted by men.

Meet some of the people featured in the December 2020 issue of The Scientist.

When submitting manuscripts to Western journals, authors face issues that go beyond language barriers.

The standard system of separating figures, tables, and legends from the text is unnecessary and laborious.

Under a two-year pilot agreement, articles published by Norwegian academics will be free to read in almost all of the publisher’s journals.

The publisher failed to meet requests for better access to research, a consortium of Norwegian institutions says.

As the American Chemical Society and Elsevier move litigation forward, other academic publishers have opted to collaborate with the academic network platform instead.

A growing number of libraries are unbundling their subscriptions to the full suite of publishers’ journals, opting for limited titles to save on costs.

The watchdog website FDAAA TrialsTracker names and shames human studies that breach the FDA’s requirements for reporting results.

A few months after the American Chemical Society won its lawsuit against the pirate site, the game of virtual whack-a-mole continues.

A consortium of 300 universities and college libraries had taken a strong stance against the publishing giant’s price hikes. 

The Scientist sat down with one of the authors of a recent analysis that quantifies the increasing incursion of open-access content into the world of scholarly publishing.

Benjamin Lewin founded Cell in 1972 at the Massachusetts Institute of Technology, and with unprecedented speed, built a collection of science journals that rival—and many say outperform—heavyweights Nature and Science.